ĀÜĄņĀŅĀ×

Ryan S. is a finance and operations professional with a robust background in investment and board governance across various high-tech and biomedical companies. Currently a member of the founding team at Kamau Therapeutics since May 2023, Ryan previously served as a board member at Forterra, where leadership included a successful Series A funding round. Other roles involve board observer contributions at ArsenalBio, Opentrons Labworks Inc., Synthego Corporation, Umoja Biopharma, and AutoStoreā„¢, as well as investor positions at Symbotic and Neuron23. Ryan's educational background includes a Bachelor of Arts in Economics and Accounting from UCLA, alongside an incomplete Bachelor of Science in Aerospace Engineering from UC Santa Barbara and a high school diploma from Bellevue High School.